OET Pharmacy Speaking: Methotrexate and Purposeful Closed Questions

Learning outcome: Use a closed question when a specific answer will guide the next action. This OET Pharmacy Speaking lesson uses weekly methotrexate for rheumatoid arthritis to practise neutral confirmation, accurate medicine histories and a clear check of understanding. It includes paired five-task cards, condition teaching, an extended pharmacist model and a repeat attempt involving a dosing error.

Open questions help a person explain their experience. Closed questions can establish a fact that must be clear, such as whether a medicine has already been taken. Good communication uses both. The problem is not that a question has a short answer; it is asking without a purpose, suggesting the preferred answer or ignoring what the patient says.

1. Original paired cards: understanding a weekly medicine

These original Jobins Training cards are independent OET preparation material, not official exam cards. They develop the source book's rheumatoid-arthritis and methotrexate case. The supplied prescription and patient details are fictional case facts for communication practice, not a recommended regimen for every patient.

Preparation prompt: Choose a reason for each closed question. “Have you taken any methotrexate yet?” determines whether you are checking a proposed plan or an actual dose history. “You have not taken any, have you?” adds an expectation and may discourage correction.

2. Understand rheumatoid arthritis and weekly methotrexate

Rheumatoid arthritis is an inflammatory condition

Rheumatoid arthritis is a long-term autoimmune condition in which the immune system attacks the lining of the joints. This can cause swelling, pain and stiffness, and over time can damage joints. Symptoms can affect everyday activities and work. The card establishes rheumatoid arthritis; the learner does not need to diagnose it from the hand symptoms.

There is no current cure, but treatment can help control disease activity and reduce the risk of damage. Explain this without predicting the individual's outcome. Mr Turner wants to use his hands for teaching music. That goal gives the treatment discussion personal meaning, but it does not justify promising that he will return to a particular activity by a fixed date.

Methotrexate changes disease activity rather than providing instant relief

Methotrexate is used as a disease-modifying treatment for rheumatoid arthritis. In plain language, it reduces the immune activity contributing to inflammation. Its benefit develops over time, so it should not be described as an immediate painkiller. The response and tolerability are reviewed by the treating team.

If symptoms have not improved quickly, the patient should not add doses or take the medicine more often. More frequent dosing is not a shortcut to benefit. Other symptom-management treatment, if needed, must follow the existing clinical plan or be reviewed appropriately. Do not add an unassessed painkiller to make the counselling sound complete.

The weekly schedule is a critical safety point

For rheumatoid arthritis, methotrexate is taken once weekly as prescribed. Taking it daily instead of weekly can cause severe toxicity and can be fatal. This is a situation where direct wording is appropriate: the patient must not convert the weekly plan into daily use. Other uses of methotrexate, such as some cancer regimens, have different specialist schedules; do not turn the rheumatoid-arthritis instruction into a claim about every use of the medicine.

The fictional plan supplies a total of 10 mg on Monday, made up of four 2.5 mg tablets taken together. The tablet strength, number of tablets and frequency are different pieces of information. “Four tablets” alone is incomplete. So is “weekly” without an agreed day. Explain the whole instruction and ask the patient to show how it fits a week.

Folic acid has a separate purpose and schedule

Folic acid is often prescribed alongside methotrexate to reduce some side effects. It is a different medicine and does not replace methotrexate. Regimens can vary. In this exercise the supplied folic-acid plan is one 5 mg tablet on Tuesday, a different day from the Monday methotrexate dose.

Use the actual labels and written plan to distinguish them. Do not assume that remembering one medicine means the patient understands the other. Do not recommend taking extra folic acid as a home treatment for a possible methotrexate overdose. An overdose needs urgent clinical advice and assessment, not an improvised correction to the weekly schedule.

Monitoring and symptoms both matter

Methotrexate monitoring includes blood counts and checks of liver and kidney function, with testing more frequent at the start or after relevant changes. The exact schedule depends on the treatment plan and individual circumstances. Confirm who is responsible, when the next test is due and how the patient will receive advice. The case supplies no normal results or booked appointment, so these cannot be assumed.

Blood tests do not make symptoms between appointments unimportant. Fever or signs of infection, unexplained bruising or bleeding, persistent cough, chest pain, new breathlessness or yellowing of the eyes or skin require prompt medical advice. Significant mouth ulcers or other concerning new symptoms also need review. Severe breathing difficulty, collapse or a serious allergic reaction needs emergency help.

A possible overdose requires action before symptoms appear

If a patient has taken more than prescribed or taken weekly methotrexate on consecutive days, seek urgent medical advice immediately, even if they feel well. Establish what was taken, the strength, amounts and times, and arrange the appropriate urgent assessment. Do not simply tell the patient to skip the next weekly dose and return at the next appointment.

In the UK, NHS advice is to contact 111 now for excess methotrexate or daily instead of weekly use. A pharmacist should use the appropriate urgent clinical pathway and emergency services for severe symptoms. The patient should take the medicine packaging and details of other medicines to assessment. They should not drive themselves if directed to A&E.

Practical support must fit the person

A clearly written weekly day, the patient card and a reminder can support safe use. Weekly methotrexate should be stored separately from daily medicines to reduce confusion. Ask what system the patient already uses before suggesting a change. If hand stiffness makes packaging difficult, discuss an appropriate pharmacy review rather than recommending unassessed repackaging.

Check all medicines, supplements and non-prescription products for interactions. The patient should ask before starting a new treatment, including over-the-counter pain relief. Alcohol, vaccination and family-planning questions should be discussed with the treating team and current medicine information. Avoid blanket assurances or detailed advice that ignores the individual's circumstances.

Clinical reading: NHS: rheumatoid arthritis; NHS: how and when to take methotrexate; NHS: methotrexate side effects; MHRA: preventing daily instead of weekly dosing; NHS Specialist Pharmacy Service: monitoring; NHS Specialist Pharmacy Service: folic acid with methotrexate.

3. Task coaching: give every focused question a job

Task 1: open the discussion, then establish current use

Begin with “What have you understood about the new treatment?” This reveals the patient's interpretation. Follow with “Have you taken any methotrexate yet?” The second question is closed because a specific fact is needed. If the answer is yes, obtain the actual dose history before continuing the proposed schedule. If it is no, clarify the plan before the first dose.

Task 2: ask neutrally and separate the facts

Do not ask, “You know it is weekly and you have only taken it on Monday, haven't you?” That sentence combines understanding, behaviour and an expected answer. Ask one thing at a time. Confirm the medicine and strength from the pack, then ask which days and how many tablets were actually taken. The purpose is accuracy, not catching the patient out.

Task 3: explain the reason without softening the key instruction

Describe the condition and the treatment's aim in plain English. Then state the weekly instruction clearly. Empathy does not require vague wording such as “perhaps avoid taking it too often.” For this prescribed rheumatoid-arthritis plan, daily dosing is unsafe. Give the reason calmly and check the patient's interpretation rather than relying on a warning alone.

Task 4: use explanation, demonstration and teach-back

The patient can agree with a yes/no question and still misunderstand how tablets are distributed across the week. Ask them to describe or point out the schedule using the labels and a simple calendar. In this case, the four methotrexate tablets are taken together on Monday, and the folic-acid tablet is on Tuesday. Correct any misunderstanding without blame, then check again.

Task 5: follow the answer into the next action

A question has not done its job merely because it was asked. If the patient cannot identify the monitoring arrangements, help clarify them. If they have already taken daily doses, move to urgent assessment. If they struggle to open packaging, explore that barrier. The recording should show a link between information gathered and the response that follows.

4. Extended pharmacist-viewpoint model with listening pauses

Only the pharmacist's spoken lines appear below. Bracketed prompts mark points where the patient's answer determines the next step. This first-attempt model assumes that no methotrexate has yet been taken.

“Hello, Mr Turner. I'm the pharmacist. I would like to go through the new methotrexate and folic-acid plan with you. What have you understood so far, and what is worrying you most?”

[Pause. Listen to the patient's interpretation before correcting it.]

“The weekly instruction feels unusual, and you are unsure whether the four tablets should be spread over different days. I'm glad you have asked. Before we look at the schedule, have you taken any methotrexate yet?”

[Pause. If the answer is yes, establish exactly what was taken and when. Do not continue this pre-start explanation if the answer suggests an error.]

“Thank you for confirming that you have not started. We can make the instruction clear before the first dose. Could we look at the packs and the specialist's written plan together? I also need to check your other medicines, including anything you buy yourself and any supplements.”

“The plan supplied here is methotrexate 10 milligrams once a week on Monday. These tablets are 2.5 milligrams each, so four tablets make the prescribed 10 milligrams. Those four tablets are taken together on Monday. They are not one tablet on four separate days.”

[Pause. Give time to compare the label and explanation. If the real labels or plan differ, resolve the discrepancy rather than forcing them to match the example.]

“For rheumatoid arthritis, this medicine must follow the once-weekly schedule. Taking it daily or more often than prescribed can cause serious harm. We will make sure the day is written clearly and that you can explain the plan in a way that makes sense to you.”

“Would it help if I explain what the medicine is intended to do for your arthritis before we look at the folic acid?”

“Rheumatoid arthritis involves inflammation because the immune system attacks the lining of the joints. Methotrexate reduces the immune activity contributing to that inflammation. The aim is to control the condition and reduce the risk of further joint damage. It is not an immediate painkiller and it is not a cure.”

[Pause. Explore the patient's expectation rather than simply adding more drug information.]

“You hope your hands will become easier to use while teaching. That is an important goal to discuss with the rheumatology team. Benefit develops over time, and the team will review your response. Please do not take extra methotrexate if you are still sore or have not noticed improvement quickly.”

“The folic acid is a separate medicine used to reduce some side effects. In your supplied plan, it is one 5 milligram tablet once a week on Tuesday. It does not replace the Monday methotrexate. Let us keep the two labels separate while we check the week.”

“Could you talk me through what you would take on Monday and Tuesday, including the number of tablets, and what you would do with the methotrexate on the other days?”

[Pause. This open check tests understanding more effectively than “Do you understand?” If the answer spreads methotrexate across days, explain again and repeat the check.]

“That is the distinction I wanted to make clear: four of the 2.5 milligram methotrexate tablets together on Monday, and the separately prescribed folic acid on Tuesday. Methotrexate is not added to a daily tablet routine.”

“What would help you remember the weekly day? Do you already use a calendar or a reminder for medicines?”

“We can make sure Monday is written in full on the appropriate label and patient card. Keep the card with you so another clinician can see that this is a weekly treatment. Store the weekly methotrexate separately from medicines taken daily. If a reminder system or packaging is difficult to use with your hands, please tell me so we can look at suitable support.”

[Pause. Use the patient's actual routine. Do not assume a phone reminder, pill organiser or family helper is available or appropriate.]

“What blood-test arrangements has the team discussed with you? Do you have a date for the next test and a contact number if you are unsure?”

“The tests check your blood cells and your liver and kidney function as part of monitoring treatment. They are usually more frequent when starting or changing treatment. We need to confirm your own schedule, rather than guess a date. If it is unclear, we should clarify it with the responsible team.”

“Please seek medical advice promptly for symptoms such as fever or infection, unexplained bruising or bleeding, significant mouth ulcers, a persistent cough or new breathlessness. Do not wait for the next routine blood test if you are concerned. Severe difficulty breathing, collapse or swelling of the mouth or throat needs emergency help.”

[Pause. Check whether the patient is describing a current symptom rather than asking about a future possibility.]

“There is one action I want to make especially clear. If you take more methotrexate than prescribed, or take it daily instead of weekly, get urgent medical advice immediately, even if you feel well. Do not try to correct that on your own by changing next week's dose or taking extra folic acid.”

“In the UK you can call 111 immediately for that advice, and we can help arrange urgent assessment through the appropriate service. Take the packaging and details of what you have taken. If there are severe symptoms, call 999.”

“What would you do if you realised that you had taken methotrexate on an extra day? I want to check that the action is clear as well as the weekly schedule.”

[Pause. Correct any plan to wait for symptoms or the next routine appointment.]

“Before adding any new medicine or supplement, check with a clinician or pharmacist who knows you take methotrexate. That includes pain relief bought without a prescription. If you have questions about alcohol, vaccinations or family planning, we should make sure you receive advice suited to your treatment and circumstances.”

“Let me summarise what we have agreed from this supplied plan. Methotrexate is weekly on Monday, with the four tablets taken together; folic acid follows its separate Tuesday instruction. We will clarify the monitoring arrangements and make the written reminder usable. What remains uncertain for you before the first dose?”

Model review: The initial closed question establishes whether the discussion concerns a proposed schedule or doses already taken. Later open checks reveal understanding. The pharmacist does not treat a sequence of yes answers as proof that the patient can use the medicines safely.

5. Speaking tips: make short questions useful

Know why you are asking. A question about whether treatment has started changes the next part of the consultation. A repeated “Are you okay?” may not clarify the relevant issue.

Avoid negative tags. “You haven't taken it daily, have you?” can sound as though one answer is expected. Ask directly and neutrally about actual days and amounts.

Ask one fact at a time. A yes to a question about the dose, folic acid, blood tests and side effects is impossible to interpret reliably. Separate the points that need confirmation.

Use a calm reason for sensitive checks. “I ask because the frequency is important for safety” explains the purpose without implying that the patient has been careless.

Check understanding through the plan. Asking the patient to describe a week gives more useful information than asking whether they understood a long explanation.

6. Useful sentences and when to use them

“Have you taken any doses yet?” Use this to distinguish a planned start from an actual medicine history. Follow a yes with the medicine, amount and timing.

“Which days did you take it?” Use this to establish behaviour without suggesting the correct answer. A calendar may help clarify the account.

“Could we check the strength on the packet?” Use this before interpreting a tablet count. A number of tablets is not meaningful without the strength.

“I ask because this medicine's frequency is important for safety.” Use this to explain a focused check, especially if the patient feels questioned repeatedly.

“Please talk me through a whole week.” Use this to test whether the patient can distinguish methotrexate from folic acid and daily medicines.

“Thank you for telling me; that changes what we need to do now.” Use this when an error is disclosed. Follow with the necessary action rather than criticism.

7. Common mistakes and practical repairs

“You understand that it is weekly, don't you?” This invites agreement. Repair: ask the patient to explain the actual days and tablets.

“Four tablets” without naming the strength and frequency. This is incomplete. Repair: state the verified total dose, tablet strength, number and weekly day together.

“Take a little each day instead.” This changes the prescribed weekly regimen unsafely. Repair: reinforce the supplied weekly plan and clarify any discrepancy with the prescriber.

“Folic acid means side effects cannot happen.” This overstates its role. Repair: explain that it reduces some side effects and that monitoring and symptom advice remain necessary.

“No symptoms means the extra doses did no harm.” This gives unsafe reassurance. Repair: arrange urgent advice after possible excess dosing even when the patient feels well.

“Just miss next Monday.” This treats a possible overdose as a scheduling problem. Repair: urgent clinical assessment comes before any revised dose plan.

8. Second attempt: daily doses have already been taken

Change the first-attempt fact that treatment has not started. It is now Wednesday. Mr Turner reveals that he took four 2.5 mg methotrexate tablets on Monday, another four on Tuesday and another four today because he thought the instruction was daily. He currently feels well. The prescribed regimen remains 10 mg once weekly on Monday.

Your task: Confirm the medicine, strength, amounts and timing without delaying help. Explain that excess methotrexate needs urgent medical advice now, even without symptoms. Tell him not to take further methotrexate while urgent clinical advice is obtained, and arrange the appropriate urgent assessment. Bring the packs and medicine history into the handover. Do not offer a home antidote, a future dose adjustment or routine follow-up as the response.

Recording review

List the closed questions you asked and identify what each answer changed. Find any question containing an expected answer, then rewrite it neutrally. Check whether your understanding check required the patient to describe the schedule. Finally, review the repeat attempt: did the disclosure of actual daily doses immediately change the consultation from education to urgent action?

Source: OET PHR 89.epub, Jobins Training. Examples labelled original or illustrative were written for this article. Independent exam preparation; no affiliation with or endorsement by the examining body. Practice does not predict an official score.